Background Advances in diagnostic and therapeutic strategies in oncology have
significantly increased the chance of survival of cancer patients, even those with metastatic …

Cancer-related cognitive impairment (CRCI) is a frequent side effect experienced by an
increasing number of cancer survivors with a significant impact on their quality of life …

Background For postmenopausal women with hormone-receptor–positive breast cancer, the
most effective duration for adjuvant therapy with an aromatase inhibitor remains unclear …

Cancer-related cognitive impairment (CRCI) is commonly experienced by individuals with
non-central nervous system cancers throughout the disease and treatment trajectory. CRCI …

Survivors of early-stage breast cancer may report treatment-related side effects that persist
for several years after the end of primary treatment. Among these, fatigue and cognitive …

Cognitive impairment is a debilitating side effect experienced by patients with cancer treated
with systemically administered anticancer therapies. With around 19.3 million new cases of …

Cancer-related cognitive impairment (CRCI) is a concerning problem for many cancer
survivors. Evaluating patients for CRCI has been a challenge, in part because of a lack of …

Epidemiological, clinical, and basic research over the past thirty years have described the
benefits of estrogen on cognition, mood, and brain health. Less is known about tamoxifen, a …

There are various cancer treatments at present, and chemotherapy is one of the main
methods. Chemotherapy‐related cognitive impairment (CRCI), as one of the side effects of …

Inflammation has been shown to predict depression, but sensitivity to inflammation varies
across individuals. Experimental studies administering potent pro-inflammatory agents have …